Assignee
TLC THERAPEUTICS LLC
US·4 granted patents·1 pending application·14 citations·filing 2017–2024
Top patents by PatentIndex Score
5 records- 0190US10561669B2Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailabilityTLC THERAPEUTICS LLC·Filed 2018·Granted Feb 18, 2020·6 cites·15 claims
- 0288US9993486B1Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailabilityTLC THERAPEUTICS LLC·Filed 2017·Granted Jun 12, 2018·8 cites·13 claims
- 0380US2024342189A1Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailabilityTLC THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 0468US12023340B2Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailabilityTLC THERAPEUTICS LLC·Filed 2021·Granted Jul 2, 2024·0 cites·13 claims
- 0568US10940155B2Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailabilityTLC THERAPEUTICS LLC·Filed 2020·Granted Mar 9, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when TLC THERAPEUTICS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →